Lv3
380 积分 2025-12-23 加入
1848MO Phase II study of firmonertinib in patients with previously treated advanced/metastatic non-small cell lung cancer (mNSCLC) with EGFR exon 20 insertion (ex20ins) mutations
10小时前
求助中
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
1个月前
已完结
The lung that rules the heart
2个月前
已完结
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
2个月前
已完结
[Chinese expert consensus on the management of cardiovascular comorbidities in patients with chronic obstructive pulmonary disease]
2个月前
已完结
Impacts of COPD exacerbation history on mortality and severe cardiovascular events among patients with COPD in China: a retrospective cohort study
2个月前
已完结
Meta‐analysis of clinical outcomes of PCSK9 modulators in patients with established ASCVD
2个月前
已完结
Inclisiran Treatment for Cardiovascular Disease Risk Reduction: A Systematic Review and Meta-Analysis
2个月前
已完结
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
2个月前
已完结
皖公网安备34019202002308
